Implementation & Dissemination of a Digital Health Intervention for Adolescent Sleep

Purpose

The goal of this study is to form a Teen Advisory Board (TAB), who will partner with our study team to co-design a beta-test a new prototype of the Firefly program, a mobile-native insomnia cognitive behavioral therapy intervention for teens. This new prototype will have addressed issues that adolescents who had used the first version of the program deemed to be barriers to engaging with the treatment.

Conditions

  • Insomnia
  • Adolescent
  • Digital Health

Eligibility

Eligible Ages
Between 13 Years and 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 13-18 years old - Self-reported insomnia symptoms

Exclusion Criteria

  • Non-English speaking

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Teen Advisory Board (TAB)/Beta Cohort 1 These teens will co-design and beta-test an app prototype.
  • Behavioral: Firefly Mobile App: A Digital Health Solution for Healthy Sleep in Teens
    A six week cognitive behavioral therapy for insomnia program delivered via a mobile app.
Beta Cohort 2 These teens will do the second round of beta-testing for the app prototype.
  • Behavioral: Firefly Mobile App: A Digital Health Solution for Healthy Sleep in Teens
    A six week cognitive behavioral therapy for insomnia program delivered via a mobile app.

Recruiting Locations

Kansas University Medical Center
Kansas City, Kansas 66103
Contact:
Emily Law, PhD
913-588-6323
elaw@kumc.edu

More Details

Status
Recruiting
Sponsor
University of Kansas Medical Center

Study Contact

Emily Law, PhD
913-588-6323
elaw@kumc.edu

Detailed Description

The aims of this study are to: 1) form a Teen Advisory Board (TAB) of teens with self-reported insomnia symptoms, 2) co-design a functional app prototype for sleep with TAB, 3) conduct two rounds of beta-testing to inform the iterative refinement of the app prototype. Participants will include 40 youth and their parents; 10 youth will participate in the TAB and first round 1 of beta-testing, and a separate cohort of 30 youth will participate in a second round of beta-testing. Youth will be ages 13-18 years and will have self-reported insomnia symptoms.